Forxiga
![Farxiga, Forxiga, Diabetes, Chronic Heart Failure, SGLT2 inhibitors, Chronic Kidney diseases, Farxiga price, Farxiga cost, Forxiga Cost, Forxiga price, Forxiga approval](https://pharmtales.com/wp-content/uploads/2023/08/FarxigaForxiga-A-New-Drug-for-Diabetes-Heart-Failure-and-Kidney-Disease.jpg)
Farxiga/Forxiga: Drug for Diabetes, Heart Failure and Kidney Disease
Anika Sharma
Farxiga is a brand name in the United States and Forxiga is the brand name in Europe and other countries. ...
![Forxiga, Chronic heart failure, Dapagliflozin, FDA approval, National Medical Products Administration](https://pharmtales.com/wp-content/uploads/2023/08/Forxiga-Receives-Green-Light-in-China-to-Mitigate-Cardiovascular-Mortality-and-Hospitalization-in-Adults-Battling-Symptomatic-Chronic-Heart-Failure.jpg)
Forxiga Receives Green Light in China to Mitigate Cardiovascular Mortality and Hospitalization in Adults Battling Symptomatic Chronic Heart Failure
Anika Sharma
China’s National Medical Products Administration (NMPA) has granted approval to Forxiga (dapagliflozin) as a groundbreaking solution in the fight against ...
![EU Approves Jardiance for CKD: Forxiga Faces Tough Rival](https://pharmtales.com/wp-content/uploads/2023/07/Jardiance-Receives-EU-Approval-for-Treating-Chronic-Kidney-Disease-CKD-Posing-a-Strong-Challenge-to-Forxiga.jpg)
Jardiance Receives EU Approval for Treating Chronic Kidney Disease (CKD), Posing a Strong Challenge to Forxiga
SG Tylor
Source – Boehringer Ingelheim The European Union has granted approval for Boehringer Ingelheim and Eli Lilly’s SGLT2 inhibitor, Jardiance (empagliflozin), ...